tradingkey.logo


tradingkey.logo


Rafael Holdings Inc

RFL
1.240USD
0.000
終倀 12/19, 16:00ET15分遅れの株䟡
64.87M時䟡総額
損倱額盎近12ヶ月PER


詳现情報 Rafael Holdings Inc 䌁業名

Rafael Holdings, Inc. is a biotechnology company. The Company holds interests in clinical and early-stage pharmaceutical companies, including a 100% interest in Cyclo Therapeutics, LLC, a biotechnology company focusing on developing its lead clinical candidate, Trappsol Cyclo, which is being evaluated in clinical trials, including an ongoing Phase III trial for the potential treatment of Niemann-Pick Disease Type C1 (NPC1), a rare, fatal, and progressive genetic disorder. It also holds an interest in LipoMedix Pharmaceuticals Ltd., a clinical-stage pharmaceutical company; Barer Institute Inc., a wholly owned preclinical cancer metabolism research operation, and an interest in Cornerstone Pharmaceuticals, Inc., a cancer metabolism-based therapeutics company. It holds an interest in Rafael Medical Devices, LLC, an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries, and a majority interest in Day Three Labs, Inc.

Rafael Holdings Incの䌁業情報


䌁業コヌドRFL
䌚瀟名Rafael Holdings Inc
䞊堎日Mar 12, 2018
最高経営責任者「CEO」Jonas (Howard S)
埓業員数21
蚌刞皮類Ordinary Share
決算期末Mar 12
本瀟所圚地520 Broad Street
郜垂NEWARK
蚌刞取匕所NASDAQ OMX NASDAQ Basic NYSE
囜United States of America
郵䟿番号07120
電話番号12126581450
りェブサむトhttps://rafaelholdings.com
䌁業コヌドRFL
䞊堎日Mar 12, 2018
最高経営責任者「CEO」Jonas (Howard S)

Rafael Holdings Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Howard S. Jonas
Mr. Howard S. Jonas
Executive Chairman of the Board, President, Chief Executive Officer
Executive Chairman of the Board, President, Chief Executive Officer
14.01M
+0.85%
Dr. Michael J. Weiss, M.D., Ph.D.
Dr. Michael J. Weiss, M.D., Ph.D.
Independent Director
Independent Director
102.49K
+0.01%
Mr. N. Scott Fine
Mr. N. Scott Fine
Non-Executive Vice Chairman of the Board
Non-Executive Vice Chairman of the Board
--
--
Mr. Joshua M. Fine
Mr. Joshua M. Fine
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Alan Grayson
Mr. Alan Grayson
Independent Director
Independent Director
--
--
Mr. Mark N. Stein, M.D.
Mr. Mark N. Stein, M.D.
Independent Director
Independent Director
--
--
Mr. Markus Walter Sieger
Mr. Markus Walter Sieger
Lead Independent Director
Lead Independent Director
--
--
Mr. David A. Polinsky
Mr. David A. Polinsky
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Susan Bernstein
Ms. Susan Bernstein
Director
Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Howard S. Jonas
Mr. Howard S. Jonas
Executive Chairman of the Board, President, Chief Executive Officer
Executive Chairman of the Board, President, Chief Executive Officer
14.01M
+0.85%
Dr. Michael J. Weiss, M.D., Ph.D.
Dr. Michael J. Weiss, M.D., Ph.D.
Independent Director
Independent Director
102.49K
+0.01%
Mr. N. Scott Fine
Mr. N. Scott Fine
Non-Executive Vice Chairman of the Board
Non-Executive Vice Chairman of the Board
--
--
Mr. Joshua M. Fine
Mr. Joshua M. Fine
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Alan Grayson
Mr. Alan Grayson
Independent Director
Independent Director
--
--
Mr. Mark N. Stein, M.D.
Mr. Mark N. Stein, M.D.
Independent Director
Independent Director
--
--

収益内蚳

䌚瀟から関連デヌタがただ開瀺されおいたせん。
䌚瀟から関連デヌタがただ開瀺されおいたせん。
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Thu, Nov 20
曎新時刻: Thu, Nov 20
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Jonas (Howard S)
27.47%
i9 PLUS, L.L.C.
7.09%
The Vanguard Group, Inc.
2.74%
Conkling (William)
0.96%
IEQ Capital LLC
0.83%
他の
60.91%
株䞻統蚈
株䞻統蚈
比率
Jonas (Howard S)
27.47%
i9 PLUS, L.L.C.
7.09%
The Vanguard Group, Inc.
2.74%
Conkling (William)
0.96%
IEQ Capital LLC
0.83%
他の
60.91%
皮類
株䞻統蚈
比率
Individual Investor
30.51%
Corporation
7.09%
Investment Advisor
4.25%
Investment Advisor/Hedge Fund
1.58%
Family Office
0.83%
Venture Capital
0.50%
Research Firm
0.46%
Hedge Fund
0.33%
他の
54.46%

機関投資家保有株


曎新時刻: Wed, Oct 1
曎新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q3
90
3.64M
7.15%
-222.66K
2025Q2
93
21.63M
63.05%
+13.10M
2025Q1
98
8.17M
28.85%
-61.05K
2024Q4
90
7.29M
30.39%
-660.45K
2024Q3
94
7.39M
31.07%
-354.11K
2024Q2
109
7.56M
31.85%
-1.78M
2024Q1
142
7.38M
31.10%
-2.82M
2023Q4
152
7.68M
32.41%
-2.73M
2023Q3
187
7.52M
31.90%
-4.47M
2023Q2
197
7.66M
32.47%
-4.19M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Jonas (Howard S)
13.89M
40.5%
-9.90K
-0.07%
Sep 13, 2025
i9 PLUS, L.L.C.
3.62M
10.54%
+390.63K
+12.11%
Jun 05, 2025
The Vanguard Group, Inc.
1.26M
3.68%
+258.36K
+25.75%
Jun 30, 2025
Conkling (William)
564.46K
1.65%
+12.64K
+2.29%
Mar 25, 2025
IEQ Capital LLC
224.03K
0.65%
-14.85K
-6.21%
Jun 30, 2025
Geode Capital Management, L.L.C.
451.14K
1.32%
+190.18K
+72.88%
Jun 30, 2025
Fine (Nathan Scott)
335.35K
0.98%
+335.35K
--
Jul 14, 2025
BlackRock Institutional Trust Company, N.A.
383.35K
1.12%
+165.56K
+76.02%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
337.13K
0.98%
-1.30K
-0.38%
Jun 30, 2025
Polinsky (David)
264.82K
0.77%
-3.25K
-1.21%
Sep 23, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
iShares Micro-Cap ETF
0%
Dimensional US Core Equity 1 ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
比率0%
Dimensional US Core Equity 1 ETF
比率0%
Avantis US Small Cap Equity ETF
比率0%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
皮類
比率
デヌタなし
日付
皮類
比率
デヌタなし

よくある質問

Rafael Holdings Incの䞊䜍5名の株䞻は誰ですか


Rafael Holdings Incの䞊䜍5名の株䞻は以䞋のずおりです。
Jonas (Howard S)は13.89M株を保有しおおり、これは党䜓の40.50%に盞圓したす。
i9 PLUS, L.L.C.は3.62M株を保有しおおり、これは党䜓の10.54%に盞圓したす。
The Vanguard Group, Inc.は1.26M株を保有しおおり、これは党䜓の3.68%に盞圓したす。
Conkling (William)は564.46K株を保有しおおり、これは党䜓の1.65%に盞圓したす。
IEQ Capital LLCは224.03K株を保有しおおり、これは党䜓の0.65%に盞圓したす。

Rafael Holdings Incの株䞻タむプ䞊䜍3皮は䜕ですか


Rafael Holdings Incの株䞻タむプ䞊䜍3皮は、
Jonas (Howard S)
i9 PLUS, L.L.C.
The Vanguard Group, Inc.

Rafael Holdings IncRFLの株匏を保有しおいる機関の数はいく぀ですか


2025Q3時点で、Rafael Holdings Incの株匏を保有しおいる機関は90瀟あり、保有株匏の総垂堎䟡倀は玄3.64Mで、党䜓の7.15%を占めおいたす。2025Q2ず比范しお、機関の持ち株は-55.90%増加しおいたす。

Rafael Holdings Incの最倧の収益源は䜕ですか


--においお、--郚門がRafael Holdings Incにずっお最倧の収益を生み出しおおり、その金額は--で、党収益の--%を占めおいたす。
KeyAI
î™